Enorama Pharma AB (publ) (STO:ERMA)

Market Cap	111.51M -38.9%
Revenue (ttm)	3.63M -72.7%
Net Income	-76.57M
EPS	-1.16
Shares Out	74.59M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	397,891
Average Volume	64,306
Open	1.445
Previous Close	1.495
Day's Range	1.305 - 2.230
52-Week Range	0.403 - 3.580
Beta	1.57
RSI	57.64
Earnings Date	Feb 17, 2026

About Enorama Pharma AB

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells medicated chewing gum in Sweden. It offers nicotine chewing gum and nicotine pouches under the NIC-S brand name. The company was incorporated in 2006 and is based in Malmö, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2006
• Employees: 5
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: ERMA

Financial Performance

In 2024, Enorama Pharma AB's revenue was 15.77 million, an increase of 1061.12% compared to the previous year's 1.36 million. Losses were -43.81 million, -1.81% less than in 2023.